Scher Howard Isador 4
4 · Asterias Biotherapeutics, Inc. · Filed Jun 25, 2018
Insider Transaction Report
Form 4
Scher Howard Isador
Director
Transactions
- Award
Stock Options
2018-06-21+20,000→ 20,000 totalExercise: $1.75Exp: 2028-06-21→ Common Stock (20,000 underlying)
Holdings
- 20,000
Stock Options
Exercise: $4.21From: 2016-04-28Exp: 2026-04-28→ Common Stock (20,000 underlying) - 20,000
Stock Options
Exercise: $3.45From: 2017-03-30Exp: 2027-03-29→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The stock options vest equally over the next four quarters, beginning on the June 30, 2018 contingent upon continued service on the Board of Directors.